The Recall Desk
Agency classClass IIIOur severity:LowFDA (Drugs)·D-910-2013·Announced 2013-08-28

Novartis Recalls Maalox Nighttime Antacid Tablets Due to Illegible Labeling

Novartis is recalling Maalox Nighttime Antacid chewable tablets because the lot number or expiration date may be illegible on the outer plastic bottle packaging.

The agency’s classification

FDA (Drugs): Class III

Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 1/5 (Low).

Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.

Our severity reasoning: The recall is classified as FDA Class III, which by definition is unlikely to cause adverse health consequences. The hazard is limited to packaging labeling issues.

Plain-English summary

Novartis Consumer Health is recalling Maalox Nighttime Antacid with Acid Reflux Barrier chewable tablets, 500 mg/200 mg, Cherry flavor, 65-count bottles. The recall involves 11,760 bottles distributed nationwide in the United States, as well as in Canada and Panama.

The recall was initiated because the lot number and/or expiration date may be illegible on the outer plastic bottle packaging. This labeling issue prevents consumers from verifying the specific lot and expiration date of the product.

Consumers who have purchased this product should check their bottles for illegible lot or expiration dates. If the information is not legible, they should stop using the product and contact Novartis Consumer Health for further instructions.

The recalled product

Product
Maalox Nighttime Antacid with Acid Reflux Barrier (calcium carbonate and alginic acid) chewable tablets, 500 mg/200 mg, Cherry flavor, 65-count tablets per bottle, Novartis Consumer Health Canada Inc., Mississauga, ON L5N 2X7, foreign labeling containing English and French, NPN…
Manufacturer
Novartis Consumer Health
Category
Drug — Antacid
Hazard
Affected units
11,760

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot #: 10114318
  • Exp 01/14

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 9 recalled by Novartis Consumer Health under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 9 products in this recall →

Related recalls

Same manufacturer · Novartis Consumer Health

See all →

Same hazard · mis labeling

See all →

Similar recalls